Delivery Order SPE2DB20D1110-SPE2DB24FK42X

Award Date 8/5/24
Potential Completion Date 8/6/24
Potential Value $14K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract valued at $11,611.20 to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the supply of Trulicity 0.75 mg/0.5 ml pens to support DLA's medical mission. This award is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen holds with DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a comprehensive range of...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The award, valued at $3,299.92, is a firm-fixed-price delivery order for the supply of Trulicity 0.75 mg/0.5 ml pens. The contract has an ultimate completion date of August 29, 2024. Amerisourcebergen, through its Corporate Office Division, will fulfill this order as part of its role as a supplier of essential pharmaceutical products and medical...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $8,708.40 firm fixed-price delivery order is for the supply of Trulicity 3 mg/0.5 ml pens to support DLA's medical programs. The contract has an ultimate completion date of August 20, 2024. Amerisourcebergen, through its Corporate Office division, is a large provider of pharmaceutical products and medical supplies to various government agencies,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Trulicity 0.75 mg/0.5 ml pens. The award, valued at $1,741.68, is a Firm Fixed Price delivery order contract with an ultimate completion date of August 30, 2024. The contract does not have a set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Trulicity 0.75 mg/0.5 ml pens. The contract is a Delivery Order with a Firm Fixed Price of $13,269.67 and a completion date of September 5, 2024. This contract is not designated as a set-aside. Amerisourcebergen Drug Corp is the prime contractor, providing these essential medical supplies to support military treatment facilities...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,500.81, is for the delivery of Trulicity 0.75 mg/0.5 ml pens. This is a delivery order under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for the supply of a comprehensive range of medical commodities to support military treatment programs...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Trulicity 0.75 mg/0.5 ml pens. The contract, valued at $9,813.60, has a firm fixed-price structure and an ultimate completion date of August 30, 2024. As this contract does not have a set-aside designation, it was awarded on an unrestricted basis. AmerisourceBergen, through its Corporate Office division, will supply these critical...
This federal contract award is for the supply of Trulicity 0.75 mg/0.5 ml pens to the Defense Logistics Agency (DLA). The $1,741.68 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on August 9, 2024. The contract has an ultimate completion date of August 12, 2024 and is not set aside. Amerisourcebergen holds several Indefinite Delivery Contracts (IDCs) with the DLA and other federal agencies, valued at up to $999,999,999 and...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation, a major pharmaceutical distributor, for the supply of Trulicity 0.75 mg/0.5 mL pens. The firm-fixed-price delivery order, valued at $1,582.68, has an ultimate completion date of September 17, 2024. This award is a part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999, for the provision of a comprehensive range of medical...
This federal contract award, valued at $1,854.94, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Trulicity 0.75 mg/0.5 ml pens. The contract is a firm fixed-price delivery order with a completion date of May 5, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global...
  • SPE2DB20D1110
    Indefinite Delivery Contract
  • SPE2DB20D1110-SPE2DB24FK42X
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor in the United States. The contract, valued at $13,778.17, is for the delivery of Trulicity 0.75 mg/0.5 ml pens to support the DLA's medical supply needs. The contract is a delivery order with a firm fixed price pricing type and has an ultimate completion date of August 6, 2024. Amerisourcebergen, through its Corporate Office division, will provide these critical pharmaceutical products to the DLA, which is a defense agency responsible for supplying a wide range of medical commodities to military treatment facilities and other federal healthcare providers. This contract award is not designated as a set-aside and is part of the DLA's broader Indefinite Delivery Contract (IDC) with Amerisourcebergen, valued at up to $999,999,999 through December 2025, for delivering a comprehensive range of medical products to support the agency's healthcare mission.

Generated 11/4/24, 9:14 AM